Metamark Genetics' Series B Round

Metamark Genetics raised a round of funding on July 16, 2010.

Metamark Genetics is a privately-held biotechnology company founded to develop novel, function-based prognostic and diagnostic tests aimed at improving urological cancer care. Metamark is a provider o…

Articles about Metamark Genetics' Series B Round: